Pfizer, Idorsia and AbbVie drug brands lead the way in pharma digital marketing — study
Endpoint News
The Annual Digital Marketing Competency Report was featured in Endpoint News. Read Now…
Reacting to Trends: Q&A With Leslie Orne, CEO of Trinity Life Sciences
Pharmaceutical Executive
Leslie Orne speaks with Pharmaceutical Executive about current trends in the life sciences industry and the ways that companies can react. Read Now…
Don’t Just Be an Armchair Leader: Interview with Leslie Orne, CEO of Trinity Life Sciences
Adam Mendler
Trinity’s President & CEO, Leslie Orne, sat down with Adam Mendler to discuss the significance of setting big goals, listening and leading by example. Read the interview to learn more. Read Now…
The Top 25 Women Leaders in Biotechnology of 2023
Healthcare Technology Report
The Healthcare Technology Report included our President & CEO, Leslie Orne, in The Top 25 Women Leaders in Biotechnology of 2023 list. Read Now…
Trinity’s Leslie Orne on the future of the pharma services sector
MM+M
Trinity Life Sciences President & CEO, Leslie Orne, gives her view on the future of pharma commercialization in an interview with Marc Iskowitz. Listen to the MM+M Medical Marketing and Media podcast to hear more. Listen Now…
The Business Case for RWE
Pharmaceutical Commerce Magazine
Trinity experts were featured in Pharmaceutical Commerce Magazine Trinity’s Nandini Hadker, Nabha Naga Subramanya and Adrienne Lovink were featured in Pharmaceutical Commerce Magazine’s article “The Business Case for RWE.” Read the article to learn more about how drugmakers can better harness real-world evidence to drive their clinical and commercial objectives, while also providing greater clarity for healthcare providers and improved access to therapy for the patients they serve. Read Now…
Does private equity have a real-world data strategy?
MM+M
As the pharma services sector continues to consolidate, RWD is emerging as a critical piece of the commercialization offering. Trinity Life Sciences’ President & CEO, Leslie Orne, was featured in an article in MM+M to discuss this topic. Read Now…
Changing the Pharmaceutical Commercialization Landscape
Fierce Biotech
Three emerging trends have the power to reshape multiple aspects of the commercialization process. These include: 1) the value of taking a phased approach to product launches, 2) the rapidly expanding potential of artificial intelligence (AI) based technologies to optimize multiple aspects of the commercialization process, and 3) the unprecedented degree to which the pricing of pharmaceutical products is under a microscope. Learn more in the new Fierce Biotech article by Leslie Orne. Read Now…
Leslie Orne – President & CEO – Trinity Life Sciences
Progress, Potential, and Possibilities Podcast
Hear from Leslie Orne, President and CEO of Trinity Life Sciences, as she shares her thoughts on strategic innovation for pharmaceutical commercialization in an interview on the Progress, Potential, and Possibilities Podcast. Listen Now…
Strategies for Success in an Evolving Commercialization Landscape
Pharmaceutical Executive
Trinity Life Sciences’ President and CEO, Leslie Orne, authored an article in Pharmaceutical Executive. To learn about strategies for success in an evolving commercial landscape, read the article. Read Now…